BROS vs BWA

The Advanced Deterministic Scorecard reveals a mixed financial profile: the Piotroski F-Score of 4/9 indicates borderline stability, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite strong revenue and earnings growth, elevated valuation multiples—P/E of 124.43 and Price/Book of 11.80—suggest the stock is pricing in aggressive future expectations. Profitability margins and ROE are above sector averages, but insider selling worth over $600M in the last six months raises concern about confidence at the top. Analysts maintain a strong_buy consensus, yet technical trend and recent price performance show weakness, indicating potential near-term headwinds.

BorgWarner Inc. (BWA) exhibits weak fundamental health with a Piotroski F-Score of 4/9, indicating marginal stability, and lacks an Altman Z-Score, raising concerns about financial distress risk. Despite a bullish analyst recommendation and strong recent price performance (+50.3% 1Y), the company faces declining earnings (YoY EPS -33%), poor profit margins (0.95%), and negative insider sentiment. Valuation metrics are mixed, with a high trailing P/E of 67.20 but a low forward P/E of 9.28, suggesting expectations of recovery. However, deteriorating earnings trends, weak dividend strength, and significant insider selling undermine the bullish case.